Types and frequencies of adverse events across clinical trials for patients with amyotrophic lateral sclerosis: an analysis of the Pooled Resource Open-Access ALS Clinical Trials (PRO-ACT) database

2026-09-16T10:17:21Z https://api.figshare.com/v2/oai The request includes illegal arguments, is missing required arguments, includes a repeated argument, or values for arguments have an illegal syntax.

Related documents

• Confirmation of Self-Reported Incident ALS Cases in the AARP-Diet and Health (AARP-DH) Cohort#810175
• This Study Evaluates the Safety, Target Engagement, and Preliminary Efficacy of Galunisertib (TGF-βR1/ALK5 Inhibitor)Combined With Nerandomilast (PDE4 Inhibitor) in GREM2-positive ALS, a Biomarker-defined Subgroup Hypothesized to Reflect Heightened TGF-β/SMAD-driven Astrocytic and Fibrotic Signaling#867967
• HD-Charge: Indirect and Out-of-Pocket Costs of Huntington's Disease in the United States#1033399
• The HIt HArd and hiT Early in Multiple Sclerosis Trial#867538
• MIROCALS: Modifying Immune Response and OutComes in ALS#859294